Mia's Feed
Medical News & Research

Expanding Diversity in Family Building Through IVF Advances

Expanding Diversity in Family Building Through IVF Advances

Share this article

Recent IVF data from Australia and New Zealand highlight increased inclusivity and technological advancements, enabling diverse family structures through safer and more effective reproductive options.

2 min read

In 2023, the use of In Vitro Fertilization (IVF) in Australia and New Zealand demonstrated a significant shift towards more inclusive family structures. Data from the Australian and New Zealand Assisted Reproduction Database (ANZARD) reveal that one in five IVF cycles were undertaken by single women or female same-sex couples, reflecting a broader understanding of infertility as a condition not limited to heterosexual couples.

The report indicates that a total of 20,417 babies were born via IVF in that year, maintaining a similar figure to the previous year. This accounts for about 1 in every 16 births in Australia and 1 in 27 in New Zealand, with a growing number of cycles performed—over 109,000—marking a 3.6% increase from 2022.

Particularly notable is the rise in IVF use among single women, with their cycles increasing from nearly 9,500 in 2020 to over 15,900 in 2023. Female same-sex couples also saw growth from 3,648 cycles in 2020 to 4,777 in 2023. Experts highlight that the evolving definition of infertility now more inclusively includes individuals facing barriers to biological parenthood based on their relationship status or sexual orientation.

Donor sperm, eggs, and surrogacy arrangements have become key components in facilitating family creation for those without partners or in same-sex partnerships. In 2023, around 60 cycles involved egg or embryo donation aimed at single men or male same-sex couples, with more than 100 births resulting from surrogacy arrangements.

Technological advances continue to shape the field. Fertility preservation techniques, such as egg and embryo freezing, have surged, especially among women choosing to safeguard their future fertility. Nearly 9,000 preservation cycles were conducted in 2023, including a rise in egg freezing for non-medical reasons. Additionally, nearly 10,000 cycles employed preimplantation genetic testing (PGT) to enhance embryo selection, with success rates improving notably among women in their early 30s.

Safety measures have also advanced. Australia and New Zealand lead globally in reducing health risks associated with multiple pregnancies by promoting single embryo transfers, resulting in record low multiple birth rates of 2.2%. Success rates of IVF have improved, with nearly 40% of women achieving pregnancy in their first cycle between 2020 and 2021. Use of frozen embryos, now at 40% of cycles, has contributed to higher success outcomes.

Overall, the trends in IVF in these countries point towards more effective, safe, and inclusive reproductive options, catering to a diverse population seeking family-building solutions.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Advanced Tool Offers More Accurate Prediction of Cardiovascular Disease Risk

A new risk prediction model by the American Heart Association offers more accurate and equitable assessment of cardiovascular disease risk across diverse populations, enhancing preventive healthcare strategies.

Innovative Bladder Cancer Therapy Reprograms Bone Marrow to Enhance Immune Response

New research uncovers how bladder cancer treatment with BCG reprograms the bone marrow to enhance the body's innate immune response, improving cancer-fighting capabilities.

Japanese Company Seeks Approval for Stem Cell Therapy to Treat Parkinson's Disease

Sumitomo Pharma is seeking regulatory approval for a pioneering stem cell therapy for Parkinson's disease, following successful clinical trials showing safety and symptom improvement.

Preventing Glaucoma-Related Vision Loss: Barriers to Care and the Need for Accessible Treatment

Glaucoma is a leading cause of blindness, but many are unable to afford the treatment needed to prevent vision loss. Barriers include high medication costs and limited access to care, especially in underserved communities. Efforts by charities and healthcare reforms are vital to address these disparities and protect eye health.